Dr. Robert S. Isaak, DO

Dr. Isaak practices at UNC Hospitals in Chapel Hill, North Carolina, part of University of North Carolina Health Care System.

Dr. Isaak's NPI, 1104020692, was assigned on June 11, 2007. Dr. Isaak holds North Carolina license 2011-00659.

Dr. Isaak's primary practice is UNC Hospitals, at 101 Manning Drive, Chapel Hill, NC 27514 in Orange County. The practice phone is (919) 966-4141.

Dr. Isaak's primary practice is UNC Hospitals in Chapel Hill, North Carolina, part of University of North Carolina Health Care System. The medical group on file is UNC Faculty Physicians. Dmand AI also links Dr. Isaak to 1 more group practice or clinic, 1 therapy and rehab clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Isaak practices, 3 sites in all. Vendor and product names are available with a free account.

Anesthesiology is Dr. Isaak's primary specialty in the NPI Registry, under taxonomy code 207L00000X. Dr. Isaak is board certified in anesthesiology by the American Board of Anesthesiology. Dr. Isaak is licensed in North Carolina.

CMS data shows 63 Medicare services from Dr. Isaak across 3 procedure codes in 2024, for 171 Medicare patients. Medicare paid $2,544 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 171 Medicare patients who saw Dr. Isaak in 2024. The largest group is 65 to 74, with 69 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 24% are also on Medicaid. Their average risk score is 2.32, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Isaak's median patient age at 70, with 55% women.

Dr. Isaak accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 13 general payments to Dr. Isaak from 4 drug and device companies from 2017 to 2025. Speaker and faculty fees make up the largest share, 73% of the total. Pacira Pharmaceuticals Incorporated paid the most, $8,697.